Table 3. Correlations between PGRMC1 abundance and clinical characteristics of RCC.
Factors | No. of patients (%) | Staining degree (average scores) | P-value |
---|---|---|---|
Gender | |||
Male | 81(60.0%) | ++ (6.95±2.97) | |
Female | 54(40.0%) | ++ (5.70±2.99) | 0.0842 |
Age | |||
<60 | 69(51.1%) | ++ (5.78±3.05) | |
≥60 | 66(48.9%) | ++ (5.72±3.01) | 0.9312 |
TNM stage | |||
I-II | 95(70.4%) | ++ (5.74±3.01) | |
III-IV | 40(29.6%) | +++(8.31±2.94) | 0.0189 |
−: Negative; +: weak immunoreactivity; ++: moderate immunoreactivity
+++: strong immunoreactivity.